(Q36402610)

14 August 2017

title

Pregnancy in women with Type 2 diabetes: who takes metformin and what is the outcome? (English)

1 reference

14 August 2017

0 references

0 references

1 reference

1 reference

Hughes RC

1

1 reference

14 August 2017

Rowan JA

series ordinal

2

1 reference

14 August 2017

language of work or name

1 reference

1 March 2006

1 reference

14 August 2017

1 reference

14 August 2017

volume

23

1 reference

14 August 2017

issue

3

1 reference

14 August 2017

page(s)

318-322

1 reference

Type 2 diabetes in pregnancy: a growing concern

14 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2006.01750.X

The differential effects of metformin on markers of endothelial activation and inflammation in subjects with impaired glucose tolerance: a placebo-controlled, randomized clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2006.01750.X

Metformin: new understandings, new uses

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2006.01750.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2006.01750.X

Physiologic and molecular alterations in carbohydrate metabolism during pregnancy and gestational diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2006.01750.X

Effects of in-utero exposure to oral hypoglycaemic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2006.01750.X

Descriptive review of the evidence for the use of metformin in polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2006.01750.X

Height, weight, and motor-social development during the first 18 months of life in 126 infants born to 109 mothers with polycystic ovary syndrome who conceived on and continued metformin through pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2006.01750.X

Pregnancy outcomes among women with polycystic ovary syndrome treated with metformin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2006.01750.X

Metformin, pre-eclampsia, and pregnancy outcomes in women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2006.01750.X

Continuing metformin throughout pregnancy in women with polycystic ovary syndrome appears to safely reduce first-trimester spontaneous abortion: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2006.01750.X

Effects of metformin on early pregnancy loss in the polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2006.01750.X

Pregnancies following use of metformin for ovulation induction in patients with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2006.01750.X

Metformin during pregnancy reduces insulin, insulin resistance, insulin secretion, weight, testosterone and development of gestational diabetes: prospective longitudinal assessment of women with polycystic ovary syndrome from preconception throughou

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2006.01750.X

Metformin therapy throughout pregnancy reduces the development of gestational diabetes in women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2006.01750.X

Metformin in management of pregnant insulin-independent diabetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2006.01750.X

Metformin reduces pregnancy complications without affecting androgen levels in pregnant polycystic ovary syndrome women: results of a randomized study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2006.01750.X

Oral hypoglycaemic agents in 118 diabetic pregnancies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2006.01750.X

High body mass index and hypercholesterolemia: risk of hypertensive disorders of pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2006.01750.X

Maternal body mass index and the risk of preeclampsia: a systematic overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2006.01750.X

Hypertensive disorders of pregnancy in women with Type 1 and Type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2006.01750.X

Pregnancy in women with Type 2 diabetes: 12 years outcome data 1990-2002.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2006.01750.X

First trimester insulin resistance and subsequent preeclampsia: a prospective study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2006.01750.X

Preeclampsia: an excessive maternal inflammatory response to pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2006.01750.X

10.1111/J.1464-5491.2006.01750.X

21 January 2018

Identifiers

DOI

1 reference

14 August 2017

1 reference